Exploring Immune Responses to Rickettsia and offering consultation concerning in vitro Babesia microti culture methodology

At Fuller Vaccine Research Laboratory, we focus on understanding the human immune response to various vector-borne rickettsial diseases, aiming to develop effective vaccines and treatments for these challenging infections.

The in vitro propagation of Babesia microti is a different project altogether. I patented a technique that had produced a year of continuous growth in vitro, then followed with an academic paper in Infection and Immunity (2024) to enlarge on this procedure. I have distributed a collection of IgM-secreting hybridomas specific for the BmSA1 attachment protein worldwide over several years. I sold the company Fuller Laboratories in January 2025, terminating my access to this collection of hybridomas, although they are still available in many laboratories worldwide. Write me with specific questions if you are still unable to propagate this parasite.

Our Mission Statement

Innovative Research and Development

Utilizing in vitro culture technology, mixed lymphocyte cultures are propagated with purified bacterial or Babesia microti antigens and followed with labelled antibodies to each component. Over several days reactivity is detected within specific cells in a specific sequence to reveal the immune reactivity sequences involved.